In the last trading session, 1.27 million Candel Therapeutics Inc (NASDAQ:CADL) shares changed hands as the company’s beta touched -0.87. With the company’s per share price at $5.70 changed hands at $0.35 or 6.54% during last session, the market valuation stood at $285.59M. CADL’s last price was a discount, traded about -156.14% off its 52-week high of $14.60. The share price had its 52-week low at $3.79, which suggests the last value was 33.51% up since then.
Analysts gave the Candel Therapeutics Inc (CADL) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CADL as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Candel Therapeutics Inc (NASDAQ:CADL) trade information
Instantly CADL was in green as seen at the end of in last trading. With action 13.77%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -34.33%, with the 5-day performance at 13.77% in the green. However, in the 30-day time frame, Candel Therapeutics Inc (NASDAQ:CADL) is 24.73% up.
Candel Therapeutics Inc (CADL) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -43.86%. The 2025 estimates are for Candel Therapeutics Inc earnings to increase by 40.03%, but the outlook for the next 5-year period is at 28.77% per year.
Candel Therapeutics Inc (NASDAQ:CADL)’s Major holders
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 2.7548% or 0.82 million shares worth $5.1 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were Fidelity Select Portfolios-Biotechnology Portfolio and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund. With 5.54 shares estimated at $31.61 million under it, the former controlled 11.07% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 1.73% of the shares, roughly 866.65 shares worth around $4.94 million.
